Innate immunity and urinary tract infection | SpringerLink
Mechanisms of pain from urinary tract infection - Rosen - 2014 - International Journal of Urology - Wiley Online Library
Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-α production through inhibition of Egr-1 expression | American Journal of Physiology-Heart and Circulatory Physiology
Sub-noxious Intravesical Lipopolysaccharide Triggers Bladder Inflammation and Symptom Onset in A Transgenic Autoimmune Cystitis Model: A MAPP Network Animal Study | Scientific Reports
Urinary Tract Infection: Pathogenesis and Outlook: Trends in Molecular Medicine
Urinary Trypsin Inhibitor Protects against Systemic Inflammation Induced by Lipopolysaccharide | Molecular Pharmacology
Frontiers | TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides
Bladder epithelial cell phosphate transporter inhibition protects mice against uropathogenic Escherichia coli infection - ScienceDirect
Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice | Laboratory Investigation
Mechanisms of pain from urinary tract infection
Prophylactic UTI attenuated LPS-induced endothelial barrier... | Download Scientific Diagram
Urinary Trypsin Inhibitor Protects against Systemic Inflammation Induced by Lipopolysaccharide | Molecular Pharmacology
Urinary Trypsin Inhibitor Protects against Systemic Inflammation Induced by Lipopolysaccharide | Molecular Pharmacology
KoreaMed Synapse
Pathogenesis of urinary tract infections with normal female anatomy - The Lancet Infectious Diseases
UTI mitigates LPS-induced inflammatory responses in HK-2 cells. A The... | Download Scientific Diagram
Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression | SpringerLink
UTI attenuates LPS-induced TNF-α (A) and IL-6 (B) expression in human... | Download Scientific Diagram
Frontiers | How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections
Frontiers | UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies
Biosensors | Free Full-Text | Nanomaterials for Biosensing Lipopolysaccharide
Histological assessment of the effects of ulinastatin (UTI) on... | Download Scientific Diagram
Full article: Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway
Urinary tract infections
Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway | Acta Pharmacologica Sinica
Molecules | Free Full-Text | A Natural Alternative Treatment for Urinary Tract Infections: Itxasol©, the Importance of the Formulation
